DS
ONCS

DRW Securities’s OncoSec Medical Incorporated ONCS Stock Holding History

DRW Securities’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-683
Closed -$210K – 94
2018
Q3 		$210K Sell
683
-135
-17% -$41.5K 0.01% 40
2018
Q2 		$248K Buy
818
+500
+157% +$175K 0.02% 59
2018
Q1 		$132K Buy
+318
New +$130K 0.01% 139

Other funds holding ONCS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

DRW Securities's ONCS Position: Q4 2018 in Review

DRW Securities sold out of OncoSec Medical Incorporated (ONCS) in Q4 2018, closing a stake of 683 shares — an estimated $210K sold.

DRW Securities first reported a position in ONCS in Q1 2018 and held it in 3 quarters. The position peaked at $248K in Q2 2018. 33 funds tracked by Wall St. Rank hold ONCS as of Q4 2018.

  • DRW Securities reported no remaining OncoSec Medical Incorporated position as of Q4 2018 after selling out during the quarter.
  • DRW Securities sold 683 OncoSec Medical Incorporated shares in Q4 2018, an estimated $210K.
  • DRW Securities first reported a position in OncoSec Medical Incorporated in Q1 2018 and held it in 3 quarters.
  • DRW Securities's OncoSec Medical Incorporated position peaked at $248K in Q2 2018.
  • 33 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2018.

Based on DRW Securities's 13F filing for Q4 2018, filed 14 Feb 2019.